PRINCETON, N.J., Oct. 13, 2017 /PRNewswire/ -- Promius Pharma LLC announced today that it is presenting 9 posters at theFall Clinical Dermatology Conference® in Las Vegas, NV, October 12-15, 2017.
The posters represent Promius Pharma's ongoing commitment to dermatological science. "Promius
Posters include findings for the disease states of acne, psoriasis, and head lice.
About Promius Pharma LLC Promius Pharma is a wholly owned subsidiary of Dr. Reddy's Laboratories, one of the largest and most respected pharmaceutical companies in the world. With a robust commercial infrastructure and extensive research and development capabilities through its parent company, Promius Pharma is committed to bringing new products to market that meet patients' needs in dermatology and neurology. For more information, visit www.promiuspharma.com.
Contact information: Promius Pharma, LLC107 College Rd EPrinceton, NJ 08540 www.promiuspharma.com
Investor Relations: Ashish Girotra[email protected] +1 (609) 375-6145
Media Relations:Lori McCreary (USA)[email protected]+1 (609) 375-2995
Copyright 2017 Promius Pharma, LLC
Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganisation , including related integration issues. The company assumes no obligation to update any information contained herein.
View original content:http://www.prnewswire.com/news-releases/announcing-progress-in-dermatological-research-promius-pharma-shares-9-posters-at-fall-clinical-dermatology-conference-300531181.html
SOURCE Promius Pharma LLC
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All